-118 patients with PCS
-Group A (OV embolisation) n=52
-Group B (Hysterectomy + BO + HRT) n=32
-Group C (Hysterectomy + UO) n=34
(3 pts. excluded, for bilateral involvement)???
One in each group with thigh varicosities
One in each group with thigh varicosities
conclusion：Significant VAS decrease in group A and B Social readjustment rating scale
In subgroup 3 embo significant only at 6m FU
To evaluate the efficacy of various treatments for pelvic congestion syndrome in patients with different stress levels, we analyzed one hundred six patients with pelvic congestion syndrome, confirmed with laparoscopy and venography, who did not respond to medication after 4-6 months medication.
为了评估各种治疗方法对不同应激水平充血综合征的疗效，分析了106例盆腔充血综合征患者，经腹腔镜和静脉造影证实，他们在4-6个月的药物治疗后没有反应。
They were divided into three groups: (embolotherapy; hysterectomy with bilateral oophorectomy and hormone replacement therapy; and hysterectomy with unilateral oophorectomy).
分为三组：（栓塞治疗；双侧卵巢切除及激素替代治疗；单侧卵巢切除）。
The visual analog ['ænəlɔ:g] scale was used to measure degree of pain; stress level data were scored with the revised social readjustment rating scale.（社会再适应评定量表）
采用视觉模拟量表测量疼痛程度；压力水平数据采用修订后的社会调整评分量表进行评分。
Embolotherapy was significantly more effective at reducing pelvic pain, compared to the other methods (p < 0.05).
与其他方法(p＜0.05)相比，栓塞治疗在减少盆腔疼痛方面更有效。
The mean percentage decrease in pain was significantly greater in the patients with lower stress scores (p < 0.05）
压力评分较低的患者疼痛的平均百分比下降明显更大(p＜0.05).
Ovarian and/or internal iliac vein embolization appears to be a safe, well-tolerated, effective treatment for pelvic congestion syndrome that has not responded to medication.
对药物没有反应的患者，卵巢和/或髂内静脉栓塞似乎是一种安全、耐受性好、有效的治疗盆腔充血综合征的方法，
|